Jon, Sangyong

Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption

Kim, C., Yang, H., Fukushima, Y., Saw, P. E., Lee, J., Park, J.-S., Park, I., Jung, J., Kataoka, H., Lee, D., et al. (2014) · Cancer Cell

Angiogenesis and VEGF in CancerProtein Kinase Regulation and GTPase Signaling

Cited by 131

A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan

Lee, E., Lee, J., & Jon, S. (2010) · Bioconjugate Chemistry

Advanced Drug Delivery SystemsDrug Solubulity and Delivery Systems

Cited by 63

Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging

Park, J., Kim, S., Saw, P. E., Lee, I.-H., Yu, M. K., Kim, M., Lee, K., Kim, Y.-C., Jeong, Y. Y., & Jon, S. (2012) · Journal of Controlled Release

Nanoparticle-Based Drug DeliveryCharacterization and Applications of Magnetic Nanoparticles

Cited by 48

Polymer Thin Film-Induced Tumor Spheroids Acquire Cancer Stem Cell-like Properties

Choi, M., Yu, S. J., Choi, Y., Lee, H. R., Lee, E., Lee, E., Lee, Y., Song, J., Son, J. G., Lee, T. G., et al. (2018) · Cancer Research

Cancer Cells and Metastasis3D Printing in Biomedical Research

Cited by 32